menu
    • menu

    Company profile for Nascent Biotech

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nascent Biotech is a California-based company focused on the development and delivery of human antibodies and cytokine responses for the treatment of cancer. The innate ability of the intelligence of the natural human immune system to generate a cancer specific response combined with Nascent Biotech’s technical skills opens the door for immunologically based therapeutics for human cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nascent BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6330 Nancy Ridge Dr, 105, San Diego, California 92121, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nascentbiotech.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nascent Biotech Receives Notification On Delayed Financial Filing
    Nascent Biotech Receives Notification On Delayed Financial Filing

    21 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/21/3012680/0/en/Nascent-Biotech-Receives-Delinquency-Notification-Related-to-its-Delayed-September-30-2024-Financial-Filing.html

    GLOBENEWSWIRE
    21 Jan 2025
    Share Share
    Nascent Biotech Presents at the July Emerging Growth Conference
    Nascent Biotech Presents at the July Emerging Growth Conference

    30 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=893877&lang=en

    ACCESSWIRE
    30 Jul 2024
    Share Share
    Nascent Biotech & HypoSpray Collab on Proprietary Transdermal Delivery System
    Nascent Biotech & HypoSpray Collab on Proprietary Transdermal Delivery System

    19 Mar 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-03-19/nascent-biotech-hypospray-pharma-collaborate-on-proprietary-transdermal-delivery-system/

    CONTRACT PHARMA
    19 Mar 2024
    Share Share
    Nascent Biotech Completes Fourth Cohort in Phase 1 Human Trial
    Nascent Biotech Completes Fourth Cohort in Phase 1 Human Trial

    13 Sep 2022

    // ACCESSWIRE

    https://www.accesswire.com/715679/Nascent-Biotech-Completes-Fourth-Cohort-in-Phase-1-Human-Trial-for-Primary-and-Metastatic-Brain-Cancer

    ACCESSWIRE
    13 Sep 2022
    Share Share
    Nascent Biotech Commencing Enrollment of Second Cohort in Phase 1 Human Trial
    Nascent Biotech Commencing Enrollment of Second Cohort in Phase 1 Human Trial

    08 Jun 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/nascent-biotech-commencing-enrollment-of-second-cohort-in-phase-1-human-trial-for-primary-and-metastatic-brain-cancer/

    BIOSPACE
    08 Jun 2021
    Share Share
    Nascent Biotech and BioRay Announce $5,000,000 Exclusive License Agreement
    Nascent Biotech and BioRay Announce $5,000,000 Exclusive License Agreement

    18 May 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/nascent-biotech-and-bioray-pharmaceutical-announce-5-000-000-exclusive-license-agreement-for-development-and-commercialization-of-nascent-s-pritumumab/

    BIOSPACE
    18 May 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search